Uso de una combinación para el melanoma que comprende la administración de cobimetinib y vemurafenib.

摘要

The present invention relates generally to the fields of molecular biology and growth factor regulation. More specifically, the invention relates to therapies for the treatment of pathological conditions, such as cancer.